Rothschild & Co Asset Management US’s PRA Health Sciences, Inc. PRAH Stock Holding History

Rothschild & Co Asset Management US’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-200,130	Closed	-$16.6M	–	358
2020 Q1	$16.6M	Sell	200,130 -17,529	-8%	-$1.71M	0.26%	148
2019 Q4	$24.2M	Sell	217,659 -9,884	-4%	-$1.02M	0.25%	173
2019 Q3	$22.6M	Sell	227,543 -4,823	-2%	-$479K	0.24%	176
2019 Q2	$23M	Sell	232,366 -1,378	-0.6%	-$132K	0.25%	175
2019 Q1	$25.8M	Buy	233,744 +10,148	+5%	+$1.06M	0.28%	136
2018 Q4	$20.6M	Sell	223,596 -1,735	-0.8%	-$176K	0.25%	157
2018 Q3	$24.8M	Sell	225,331 -21,175	-9%	-$2.2M	0.25%	164
2018 Q2	$23M	Sell	246,506 -64,400	-21%	-$5.55M	0.25%	166
2018 Q1	$25.8M	Sell	310,906 -2,134	-0.7%	-$190K	0.29%	153
2017 Q4	$28.5M	Buy	+313,040	New	+$26M	0.3%	136

Other funds holding PRAH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NIPH

NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return

Pendal Group Sydney, Australia $11.6B AUM 12.87% 1-Year Est. Return

Rothschild & Co Asset Management US's PRAH Position: Q2 2020 in Review

Rothschild & Co Asset Management US sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2020, closing a stake of 200,130 shares — an estimated $16.6M sold.

Rothschild & Co Asset Management US first reported a position in PRAH in Q4 2017 and held it in 10 quarters. The position peaked at $28.5M in Q4 2017. 293 funds tracked by Wall St. Rank hold PRAH as of Q2 2020.

Rothschild & Co Asset Management US reported no remaining PRA Health Sciences, Inc. position as of Q2 2020 after selling out during the quarter.
Rothschild & Co Asset Management US sold 200,130 PRA Health Sciences, Inc. shares in Q2 2020, an estimated $16.6M.
Rothschild & Co Asset Management US first reported a position in PRA Health Sciences, Inc. in Q4 2017 and held it in 10 quarters.
Rothschild & Co Asset Management US's PRA Health Sciences, Inc. position peaked at $28.5M in Q4 2017.
293 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2020.

Based on Rothschild & Co Asset Management US's 13F filing for Q2 2020, filed 10 Aug 2020.